Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0001842190-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 9, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
44,471
Total Value
$0.00
P&L
+inf% (+$2,868,824.21)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Stock Option (right to buy) | Derivative | Mar 5, 2026 | Grant/Award | 27,310 | $0.00 | $0.00 | 27,310 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Units | Derivative | Mar 5, 2026 | Grant/Award | 17,161 | $0.00 | $0.00 | 17,161 | Direct | โ | View Details |